World Health Organization: Infection Prevention and Control (IPC) for Novel Coronavirus (COVID-19)

$0.00

Property of the World Health Organization

 

This one-hour course provides information on what facilities should be doing to be prepared to respond to a case of an emerging respiratory virus such as the novel coronavirus, how to identify a case once it occurs, and how to properly implement IPC measures to ensure there is no further transmission to HCW or to other patients and others in the healthcare facility.

This training is intended for healthcare workers and public health professionals, as it is focused on infection prevention and control.

 

Click to be taken to the WHO website and course.

 

Objectives

Upon completion of this course, you should be able to:

  • define IPC and its role in the context of preparedness, readiness and response;
  • describe the current epidemiological COVID-19 situation, including case definitions and signs & symptoms;
  • describe source control, administrative controls and environmental and engineering controls;
  • describe the WHO-recommended IPC measures for health care facilities, including when dealing with suspect or confirmed COVID-19 cases;
  • describe additional IPC measures to be taken to assist in general preparedness within a health care facility.
SKU: 282047 Category:

Description

This course — created and provided by the World Health Organization — provides information on what facilities should be doing to be prepared to respond to a case of an emerging respiratory virus such as the novel coronavirus, how to identify a case once it occurs, and how to properly implement IPC measures to ensure there is no further transmission to HCW or to other patients and others in the healthcare facility.

This training is intended for healthcare workers and public health professionals, as it is focused on infection prevention and control.

Reviews

There are no reviews yet.

Be the first to review “World Health Organization: Infection Prevention and Control (IPC) for Novel Coronavirus (COVID-19)”

Your email address will not be published. Required fields are marked *